pharma · Advanced Solid Tumor · Sarcoma · PRLD
Prelude Therapeutics
Prelude Therapeutics Inc
Prelude Therapeutics clinical programs — 11 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 175 Innovation Boulevard, Wilmington, DE 19805, US
- Founded
- 2016
- Employees
- 111
- Programs
- 13
- Drugs
- 5
- Patents
- 16
Prelude Therapeutics projects
11 ClinicalTrials.gov programs sponsored by Prelude Therapeutics.
Prelude Therapeutics has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
PRT12396
Prelude Therapeutics Inc
Polycythemia Vera (PV)
1 trial -
PRT1419
Prelude Therapeutics Inc
Acute Myeloid Leukemia
1 trial -
PRT1419
Prelude Therapeutics Inc
Multiple Myeloma
1 trial -
PRT1419
Prelude Therapeutics Inc
Sarcoma
1 trial -
PRT2527
Prelude Therapeutics Inc
Sarcoma
1 trial -
PRT2527
Prelude Therapeutics Inc
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
1 trial -
PRT3645
Prelude Therapeutics Inc
Breast Cancer
1 trial -
PRT543
Prelude Therapeutics Inc
Relapsed/Refractory Advanced Solid Tumors
1 trial -
PRT7732
Prelude Therapeutics Inc
Advanced Solid Tumor
1 trial -
PRT7732-01
Prelude Therapeutics Inc
esophageal, gastric, or gastroesophageal junction adenocarcinoma, esophageal, gastric, or gastroesophageal junction squamous cell carcinoma, Non-small cell lung cancer (NSCLC), Advanced or Metastatic Solid Tumors with a SMARCA4 Mutation
1 trial -
PRT811
Prelude Therapeutics Inc
Advanced Solid Tumor
1 trial
Frequently asked questions
How many clinical projects does Prelude Therapeutics have?
11 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.